Get started
Author

Anum Abbas

Renal Toxicities of Targeted Therapies
2015 · Anum Abbas, Mohsin M. Mirza, et al. · Targeted Oncology · 87
Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Adolescents: A Randomized Clinical Trial
2023 · Germán Áñez, Lisa M. Dunkle, et al. · JAMA Network Open · 60
PDF
Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies
2024 · Erica J. Stohs, Anum Abbas, et al. · Transplant Infectious Disease · 37
PDF
Neuroinvasive West Nile virus infections after solid organ transplantation: Single center experience and systematic review
2022 · Anum Abbas, Fang Qiu, et al. · Transplant Infectious Disease · 28
PDF
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials
2023 · Deborah A. Theodore, Angela R. Branche, et al. · JAMA Network Open · 24
PDF
Risk of COVID-19 after natural infection or vaccination
2023 · Anne-Marie Rick, Matthew B. Laurens, et al. · EBioMedicine · 22
PDF
Viral Enteritis in Solid-Organ Transplantation
2021 · Anum Abbas, Andrea J. Zimmer, et al. · Viruses · 20
PDF
Intracranial toxoplasmosis presenting as panhypopituitarism in an immunocompromised patient
2015 · Shadi Hamdeh, Anum Abbas, et al. · The American Journal of Emergency Medicine · 14
Beta‐lactam allergies, surgical site infections, and prophylaxis in solid organ transplant recipients at a single center: A retrospective cohort study
2022 · Clayton Mowrer, Elizabeth Lyden, et al. · Transplant Infectious Disease · 12
PDF
Infectious complications among CD19 CAR‐T cell therapy recipients: A single‐center experience
2023 · Bryan Walker, Andrea J. Zimmer, et al. · Transplant Infectious Disease · 9
PDF
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials
2025 · Leah I. B. Andrews, M. Elizabeth Halloran, et al. · JAMA Network Open · 8
PDF
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials
2024 · Leigh H. Fisher, Jia Jin Kee, et al. · JAMA Network Open · 8
Pritelivir Demonstrated Superior Efficacy Compared to Investigator’s Choice Treatment for Refractory Herpes Simplex Virus Infections In Immunocompromised Patients: PRIOH-1, Phase 3 Safety and Efficacy
2026 · Genovefa A Papanicolaou, Robin K. Avery, et al. · Transplantation and Cellular Therapy · 7
Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review
2022 · Abubakar Tauseef, Maryam Zafar, et al. · Journal of Family Medicine and Primary Care · 7
ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial
2023 · Sarah Nikiforow, Mitchell Horwitz, et al. · Blood · 6
Antibiotic Prescribing for Acute Respiratory Illnesses in Persons With HIV Compared With Persons Without HIV
2022 · Mackenzie R Keintz, Anum Abbas, et al. · Open Forum Infectious Diseases · 6
PDF
Role of steroids in critically-ill sepsis patients: a review article and literature to review
2021 · Mohsin Mirza, Maryam Zafar, et al. · Journal of Community Hospital Internal Medicine Perspectives · 5
ALVR106, an Off-the-Shelf, Multivirus-Specific T-Cell Therapy, for the Treatment of Respiratory Viral Infections: Results from a Phase 1, First-in-Human, Dose-Ranging Trial
2024 · Sarah Nikiforow, Mitchell Horowitz, et al. · Transplantation and Cellular Therapy · 4
Hemophagocytic lymph histiocytosis (HLH): etiologies, pathogenesis, treatment, and outcomes in critically ill patients: a review article and literature to review
2021 · Mohsin Mirza, Maryam Zafar, et al. · Journal of Community Hospital Internal Medicine Perspectives · 4
Decoding COVID-19: phenotypes and the pursuit of precision medicine
2025 · Sias J. Scherger, Carlos A. Gomez, et al. · Clinical Microbiology and Infection · 3
The Role of Ribavirin for Treatment of Respiratory Syncytial Virus in Immunocompromised Patients
2025 · Anum Abbas, Sias Scherger, et al. · Current treatment options in infectious diseases/Current treatment options in infectious disease · 3
Plasma microbial cell-free DNA sequencing in transplant and haematologic patients—promise, pitfalls, and path forward
2025 · Carlos A. Gomez, Sias J. Scherger, et al. · Clinical Microbiology and Infection · 1
Are All Cytokine Storms Born Equal?
2025 · Andre C. Kalil, Anum Abbas, et al. · JAMA Network Open · 1
PDF
527. New Robust Antimicrobial Stewardship Program (ASP) Results in Reduction of Clostridium difficile 30-Day Readmission
2018 · Jennifer Anthone, Anum Abbas, et al. · Open Forum Infectious Diseases · 1
PDF
440.2: Immune response and safety of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (adjuvanted RSVPreF3) in immunocompromised (IC) adults with lung or kidney transplant compared to non-IC adults up to 12 months post-vaccination.
2026 · Catherine Small, Deepali Kumar, et al. · Transplantation
Works count: 36
Citation count: 377
H-index: 9
I10-index: 9
Year
Topic
Type